New Study Suggests Underestimated Long COVID Cases

Written By Delainne Bond

ProMedView Strategic Clinical Solutions continues to gather information about Neuro COVID and resources for those experiencing post COVID condition.

It appears the newest COVID-19 variants have the ability to slip by the antibody response people have built from prior infections and the vaccination. This means everyone is vulnerable, and the risks of neuro COVID, organ failure, hospitalizations, and death are higher.

SOURCE: WorkersCompensation.com

AUTHOR: F.J. Thomas

ARTICLE EXCERPT According to data from the CDC, in the last week of August 2023, the number of COVID related hospitalizations increased 15.7, and the number of deaths increased 17.6 percent. The CDC has been monitoring an increase that has occurred for 7 weeks, and some estimates are projected as high as 1,700 to 9,700 daily COVID hospital admissions by the end of September.

While victims of COVID overcame the initial symptoms, many suffered ongoing side effects that eventually became known as Long COVID. Some of the symptoms of Long COVID include cognitive issues, headache, insomnia, dizziness, change in smell or taste, and depression or anxiety. As a result of the multitude of long term symptoms, estimates show that around 15 percent of unfilled jobs can be attributed to Long Covid, and around 25 percent of workers with Long COVID had to reduce their working hours. With an influx of new COVID cases, the potential overall impact of Long COVID could be devastating to the workplace. 

It’s estimated that around a third of those that contracted COVID developed Long COVID. However, a recent study published in Neurology: Neuroimmunology & Neuroinflammation speculates that number may be an underestimate, as previous studies have been largely based on patients who had a positive COVID test.

Read the full article here.

Early diagnosis and early intervention are the keys to minimizing these risks. ProMedView has workforce resources and solutions to mitigate the risks associated with COVID and COVID complications.

Delainne Bond

Delainne Bond, BSN, RN, holds dual degrees in Nursing and Neuropsychology. She is the Principal Consultant with ProMedView, Founder of the covidCAREgroup, and a PRIMA Board Member with the Tampa, Florida chapter.

Recognized as a leader in clinical solutions for complex injuries and illnesses, Delainne has a broad spectrum of clinical experience including Workers’ Compensation, acute and critical care in the hospital setting, occupational medicine, and community health.

In the national Workers’ Compensation arena, Delainne is a CEU Educator, and her experience includes leadership, risk management, catastrophic case management, mass casualty incident response, critical incident management, and provider network development.

Since the event of the pandemic, Delainne has devoted her clinical expertise to researching Long COVID, offering education and resources on a global scale through the covidCAREgroup.

In addition to educating providers, clinicians, attorneys, case managers, and nurses, Delainne has published many articles about Long COVID with ~6 million views in 2022. She runs the largest clinical social media support groups in the world with followers and collaborators including physicians, clinicians, and business leaders from 110 countries.

https://www.promedview.com
Previous

SARS-CoV-2–Specific Immune Responses in Patients With Postviral Syndrome After Suspected COVID-19
Next

WORKFORCE WELLNESS RISK FORECAST REPORT - RAIsonance, Fall 2023